ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
5.34
+0.01 (0.19%)
At close: Aug 28, 2026, 4:00 PM EDT
5.33
-0.01 (-0.19%)
After-hours: Aug 28, 2026, 4:10 PM EDT
ImageneBio Employees
ImageneBio had 18 employees as of June 30, 2026. The number of employees increased by 9 or 100.00% compared to the same quarter last year.
Employees
18
Change
9
Growth
100.00%
Revenue / Employee
n/a
Profits / Employee
-$2,962,778
Market Cap
60.62M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 18 | 9 | 100.00% |
| Mar 31, 2026 | 17 | 8 | 88.89% |
| Dec 31, 2025 | 15 | 5 | 50.00% |
| Mar 31, 2025 | 9 | - | - |
| Dec 31, 2024 | 10 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Heron Therapeutics | 128 |
| Alps Group | 93 |
| Xilio Therapeutics | 76 |
| Boundless Bio | 28 |
| INmune Bio | 21 |
| Edesa Biotech | 17 |
| Serina Therapeutics | 16 |
| MiNK Therapeutics | 15 |
IMA News
- 9 days ago - ImageneBio initiated with a Buy at H.C. Wainwright - TheFly
- 13 days ago - ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 25 days ago - ImageneBio registers to sell 5.77M shares of common stock for holders - TheFly
- 25 days ago - ImageneBio files $200M mixed securities shelf - TheFly
- 25 days ago - ImageneBio reports Q2 EPS (63c), consensus (98c) - TheFly
- 25 days ago - ImageneBio Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 7 weeks ago - ImageneBio appoints Matt Robbins as general counsel - TheFly
- 7 weeks ago - ImageneBio Appoints Matt Robbins as General Counsel - GlobeNewsWire